QA: Amicus Therapeutics INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2026_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 676,173,000
1 IntangibleAssetsNetIncludingGoodwill 211,712,000
2 PropertyPlantAndEquipmentNet 27,108,000
3 remainder_Assets 34,877,000
4 LiabilitiesCurrent 237,828,000
5 LiabilitiesNoncurrent 45,141,000
6 remainder_Liabilities 392,660,000
7 CostOfGoodsAndServicesSold 130,276,770
8 SellingGeneralAndAdministrativeExpense 527,737,820
9 ResearchAndDevelopmentExpense 147,577,879
10 remainder_Expenses 85,861,946
11 remainder_Revenues 716,071,651
12 remainder_NetIncome 8,416,587
13 remainder_ComprehensiveNetIncome 9,072,433
  yvar yval
0 Assets 949,870,000
1 Liabilities 675,629,000
2 Expenses 891,454,415
3 Revenues 716,071,651
4 StockholdersEquity 274,241,000
5 NetIncome -166,966,177
6 ComprehensiveNetIncome -162,429,960
7 BaseVar 1,625,257,043
8 EconomicCapitalRatiobeforeLimitedLiability 0.536
9 EconomicCapitalRatio 1.91

Edgar->Model Mapping

Feature Distribution

Change over Time